Renapharma Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • 2ndary - Private
  • Financing Rounds
  • 2

Renapharma General Information

Description

Provider of iron medicines intended to improve patient's every day life. The company's iron medicines combine scientific knowledge and innovative technology, enabling patients to treat Vitamin D deficiency, particularly in indication groups for nephrology, gastroenterology and internal medicine. It also provides an application through which user can get reminders about their doses and record adherence to treatment.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Application Software
Pharmaceuticals
Parent Company
Primary Office
  • P.O. Box 938
  • 751 09 Uppsala
  • Sweden
+46 018-700 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Renapharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Renapharma‘s full profile, request access.

Request a free trial

Renapharma Executive Team (1)

Name Title Board Seat Contact Info
Bo Danielson Ph.D Founder
To view Renapharma’s complete executive team members history, request access »